Traduction de «effectiveness of treatement for drug » (Français → Néerlandais) :

Effectiveness of treatement for drug abuse : an overview of the DARP R
Effectiveness of treatement for drug abuse : an overview of the DA

Commenté des Médicaments 34 , Farmacotherapeutisch Kompas 35 , British National Formulary 36 , Martindale 37 , Meyler’s Side Effects of Drugs 38 , Geriatric Dosage Handbook 39 , Managing Clinically Important Drug Interactions 40 , Drug Information AHFS 41 .
Gecommentarieerd Geneesmiddelenrepertorium 34 , Farmacotherapeutisch Kompas 35 , British National Formulary 36 , Martindale 37 , Meyler’s Side Effects of Drugs 38 , Geriatric Dosage Handbook 39 , Managing Clinically Important Drug Interactions 40 , Drug Information AHFS 41 .

348, 529-537 (2003) W.E. Evans et H.L. McLeod: Pharmacogenomics - Drug disposition, drug targets and side effects.
348, 529-537 (2003) W.E. Evans en H.L. McLeod: Pharmacogenomics - Drug disposition, drug targets and side effects.

Liste des abréviations utilisées AR Arrêté royal CE Communauté européenne cGTP Current Good Tissue Practice CSS Conseil Supérieur de la Santé EN European norms EU GMP European Union's good manufacturing practice FDA Food and Drug Administration FMEA Failure Mode and Effects Analysis HACCP Hazard Analysis and Critical Control Points HEPA High-efficiency particulate air HVAC Heating, ventilation, and air conditioning ICSI Injection intracytoplasmique de sperme ISO International Organization for Standardization MCH Matériel corporel humain NBN Bureau de Normalisation OMS Organisation mondiale de la santé TSA Tryptic Soy Agar UFC Unité formant colonie ULPA Ultra-low particulate air US United States USP United States Pharmacopeia
Lijst van de gebruikte afkortingen cGTP Current Good Tissue Practice EG Europese Gemeenschap EN Europese normen EU GMP European Union’s good manufacturing practice FDA Food and Drug Administration FMEA Failure Mode and Effects Analysis HACCP Hazard Analysis and Critical Control Points HEPA High-efficiency particulate air HGR Hoge Gezondheidsraad HVAC Heating, ventilation, and air conditioning ICSI Intra cytoplasmatische sperma injectie ISO International Organization for Standardization KB Koninklijk besluit KVE Kolonievormende eenheden MLM Menselijk lichaamsmateriaal NBN Nationale Belgische normen TSA Tryptic Soy Agar ULPA Ultra-low particulate air USP United States Pharmacopeia VS Verenigde Staten WHO World Health Organisation

effectiveness of a public health model for local drug policy.
circuit: genesis and effectiveness of a public health model for local drug policy.

Food and Drug Administration Generally Recognised As Safe Natural Food Colours Association No Observed Adverse Effect Level World Health Organisation
Natural Food Colours Association No Observed Adverse Effect Level World Health Organisation

D’après Meyler’s Side Effects of Drugs et Martindale, toutes les héparines, y compris les héparines de bas poids moléculaire, peuvent provoquer dans de rares cas une hyperkaliémie, surtout lorsque le traitement dépasse les 7 jours; celle-ci peut être cliniquement importante, a fortiori en présence d’autres facteurs de risque.
Volgens Meyler’s Side Effects of Drugs en Martindale kunnen alle heparines, met inbegrip van de heparines met laag moleculair gewicht, in zeldzame gevallen hyperkaliëmie veroorzaken, vooral bij behandeling gedurende meer dan 7 dagen, en kan deze zeker in aanwezigheid van andere risicofactoren klinisch belangrijk zijn.

42. Casas JP, Chua W, Loukogeorgakis S, et al. Effect of the inhibitors of the rennin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis.
41. Fored M, Ejerblad E, Lindblad P et al. Acetaminophen, aspirin, and chronic renal failure. N Engl J Med 2001; 345:1801-8.

Extrapyramidal motor side-effects of first- and second-generation antipsychotic drugs.
Extrapyramidal motor side-effects of first- and secondgeneration antipsychotic drugs.

Gauthier K, Bai A, Perras C et al ; Canadian Agency for Drugs and Technologies in Health. Denosumab, raloxifene, and zoledronic acid for the treatment of postmenopausal osteoporosis : clinical effectiveness and harms.
postmenopausal osteoporosis : clinical effectiveness and harms.